These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

383 related articles for article (PubMed ID: 11680261)

  • 1. The costs of nonsedating antihistamine therapy for allergic rhinitis in managed care: an updated analysis.
    Liao E; Leahy M; Cummins G
    Am J Manag Care; 2001 Oct; 7(15 Suppl):S459-68. PubMed ID: 11680261
    [TBL] [Abstract][Full Text] [Related]  

  • 2. A descriptive analysis of the use and cost of new-generation antihistamines in the treatment of allergic rhinitis: a retrospective database analysis.
    Lee J; Cummins G; Okamoto L
    Am J Manag Care; 2001 May; 7(4 Suppl):S103-12. PubMed ID: 11392821
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Economic burden of rhinitis in managed care: a retrospective claims data analysis.
    Dalal AA; Stanford R; Henry H; Borah B
    Ann Allergy Asthma Immunol; 2008 Jul; 101(1):23-9. PubMed ID: 18681080
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Optimizing quality of care and cost effectiveness in treating allergic rhinitis in a managed care setting.
    Nash DB; Sullivan SD; Mackowiak J
    Am J Manag Care; 2000 Jan; 6(1 Suppl):S3-15; quiz S19-20. PubMed ID: 11009751
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Treating allergic rhinitis with second-generation antihistamines.
    Nightingale CH
    Pharmacotherapy; 1996; 16(5):905-14. PubMed ID: 8888086
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Efficacy and tolerability of loratadine versus fexofenadine in the treatment of seasonal allergic rhinitis: a double-blind comparison with crossover treatment of nonresponders.
    Prenner BM; Capano D; Harris AG
    Clin Ther; 2000 Jun; 22(6):760-9. PubMed ID: 10929922
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Treatment of allergic rhinitis: an evidence-based evaluation of nasal corticosteroids versus nonsedating antihistamines.
    Stempel DA; Thomas M
    Am J Manag Care; 1998 Jan; 4(1):89-96. PubMed ID: 10179909
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Current concepts and therapeutic strategies for allergic rhinitis in school-age children.
    Blaiss M
    Clin Ther; 2004 Nov; 26(11):1876-89. PubMed ID: 15639699
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Costs of second-generation antihistamines in the treatment of allergic rhinitis: US perspective.
    Hay JW; Kaliner MA
    Curr Med Res Opin; 2009 Jun; 25(6):1421-31. PubMed ID: 19422280
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Impact of interventions designed to increase market share and prescribing of fexofenadine at HMOs.
    Benedetto SR; Sloan AS; Duncan BS
    Am J Health Syst Pharm; 2000 Oct; 57(19):1778-85. PubMed ID: 11030030
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Link between patient preferences and treatment outcomes in seasonal allergic rhinitis: an empiric investigation.
    Ricard N; Kind P; Christian S; Jensen M; Stewart J
    Clin Ther; 1999 Jan; 21(1):268-77. PubMed ID: 10090440
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Assessing patient satisfaction with desloratadine after conversion from loratadine, fexofenadine, or cetirizine.
    Glass D; Harper A
    Manag Care Interface; 2004 Feb; 17(2):29-34. PubMed ID: 15038691
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Economic outcomes of a targeted intervention program: the costs of treating allergic rhinitis patients.
    Santos R; Cifaldi M; Gregory C; Seitz P
    Am J Manag Care; 1999 Apr; 5(4 Suppl):S225-34. PubMed ID: 10387543
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Loratadine versus cetirizine: assessment of somnolence and motivation during the workday.
    Salmun LM; Gates D; Scharf M; Greiding L; Ramon F; Heithoff K
    Clin Ther; 2000 May; 22(5):573-82. PubMed ID: 10868555
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Patient characteristics and prescription fill patterns for allergic rhinitis medications, with a focus on montelukast, in a commercially insured population.
    Bollinger ME; Diette GB; Chang CL; Stephenson JJ; Sajjan SG; Fan T; Allen-Ramey FC
    Clin Ther; 2010 Jun; 32(6):1093-102. PubMed ID: 20637964
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Asthma rescue and allergy medication use among asthmatic children with prior allergy prescriptions who initiated asthma controller therapy.
    Luskin A; Bukstein D; Kocevar VS; Yin DD
    Ann Allergy Asthma Immunol; 2005 Aug; 95(2):129-36. PubMed ID: 16136761
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Comparative effects of desloratadine, fexofenadine, and levocetirizine on nasal adenosine monophosphate challenge in patients with perennial allergic rhinitis.
    Lee DK; Gardiner M; Haggart K; Fujihara S; Lipworth BJ
    Clin Exp Allergy; 2004 Apr; 34(4):650-3. PubMed ID: 15080821
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Levocetirizine for the treatment of allergic rhinitis and chronic idiopathic urticaria in adults and children.
    Singh-Franco D; Ghin HL; Robles GI; Borja-Hart N; Perez A
    Clin Ther; 2009 Aug; 31(8):1664-87. PubMed ID: 19808127
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Outcomes and cost comparison of three therapeutic approaches to allergic rhinitis.
    Fairchild CJ; Durden E; Cao Z; Smale P
    Am J Rhinol Allergy; 2011; 25(4):257-62. PubMed ID: 21639996
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Assessing satisfaction with desloratadine and fexofenadine in allergy patients who report dissatisfaction with loratadine.
    Glass DJ; Harper AS
    BMC Fam Pract; 2003 Aug; 4():10. PubMed ID: 12917016
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 20.